Goodsense
Mini Nicotine Polacrilex Lozenge 4mg, Mint, 81-Count, Stop Smoking Aid, GoodSense Smoking Cessation Products
Free shipping with 3 or more products in your cart
Payflex: Pay in 4 interest-free payments of R383.50. Read the FAQ
R 1,534
In stock
Duties, insurance and VAT included
Delivered in 10–20 working days —
Free shipping with 3 or more products in your cart
Secure checkout
Your payment is fully protected
Duties & VAT included
No surprise charges at the door
Tracked delivery
Track your order end to end
Returns support
30-day return window
Description
- MINI NICOTINE LOZENGE: Mini Nicotine Polacrilex Lozenge 4mg is part of a Nicotine Replacement Therapy, a treatment to help people stop smoking. Compare to the active ingredient of Nicorette mini lozenges
- SMOKING CESSATION: Nicotine Replacement Theory is designed to wean your body off cigarettes. It helps regulate, control and gradually reduce your body's cravings for nicotine.
- QUITTING SMOKING: Smoking has two addictive components, a physical and a mental need for the nicotine in tobacco.
- STOP SMOKING AID: Mini Nicotine lozenges reduce withdrawal symptoms, including nicotine craving, associated with quitting smoking.
- USE: To improve your chances of quitting smoking, use at least 9 pieces of Mini Nicotine Polacrilex Lozenges a day for the first 6 weeks. However, do not take more than 20 nicotine lozenges per day.
Good Sense Nicotine Polacrilex Lozenge 4 mg (nicotine), Mint Mini Lozenge reduces withdrawal symptoms, including nicotine craving, associated with quitting smoking. Compare to the active ingredient of Nicorette mini Lozenge.
Technical Specifications
Manufacturer
Perrigo Company
Color
Mint
Size
81 Count (Pack of 1)
Height
11.1 cm
Length
8.6 cm
Width
5.4 cm
Weight
0.03 kg
Release date
13 March 2014
Shipping & Delivery
Your order is shipped from the USA and delivered to your door in South Africa in 10–20 working days. All items are fully tracked.
Returns & Exchanges
We offer a 30-day return window. If something isn't right, contact our support team and we'll make it right.